ATC Group: R06AD02 Promethazine

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of R06AD02 in the ATC hierarchy

Level Code Title
1 R Respiratory system
2 R06 Antihistamines for systemic use
3 R06A Antihistamines for systemic use
4 R06AD Phenothiazine derivatives
5 R06AD02 Promethazine

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 25 mg
PAREN - Parenteral 25 mg
RECTAL - Rectal 25 mg

Active ingredients in R06AD02

Active Ingredient Description
Promethazine

Promethazine is a potent, long acting, antihistamine with additional anti-emetic central sedative and anti-cholinergic properties.

Related product monographs

Title Information Source Document Type  
AVOMINE Tablet Medicines and Medical Devices Safety Authority (NZ) MPI, EU: SmPC
PHENERGAN Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
PHENERGAN Solution for injection FDA, National Drug Code (US) MPI, US: SPL/Old
SOMINEX Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicines in this ATC group

United States (US)

Canada (CA)

Cyprus (CY)

France (FR)

Germany (DE)

Ireland (IE)

Israel (IL)

Japan (JP)

Malta (MT)

Poland (PL)

Singapore (SG)

Tunisia (TN)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.